103 related articles for article (PubMed ID: 27470447)
1. Retinoids and PPAR agonists: Promising partners in neurodegenerative diseases?
Riancho J
Free Radic Biol Med; 2016 Aug; 97():616-617. PubMed ID: 27470447
[No Abstract] [Full Text] [Related]
2. Relaunching an old drug: the potential role of bexarotene in neurodegenerative diseases.
Riancho J; Berciano MT; Berciano J; Lafarga M
J Neurol; 2016 Jan; 263(1):177-8. PubMed ID: 26725092
[No Abstract] [Full Text] [Related]
3. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.
Kawahara K; Suenobu M; Ohtsuka H; Kuniyasu A; Sugimoto Y; Nakagomi M; Fukasawa H; Shudo K; Nakayama H
J Alzheimers Dis; 2014; 42(2):587-605. PubMed ID: 24916544
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin.
Tippmann F; Hundt J; Schneider A; Endres K; Fahrenholz F
FASEB J; 2009 Jun; 23(6):1643-54. PubMed ID: 19144697
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid receptor agonists regulate expression of ATP-binding cassette transporter G1 in macrophages.
Ayaori M; Yakushiji E; Ogura M; Nakaya K; Hisada T; Uto-Kondo H; Takiguchi S; Terao Y; Sasaki M; Komatsu T; Iizuka M; Yogo M; Uehara Y; Kagechika H; Nakanishi T; Ikewaki K
Biochim Biophys Acta; 2012 Apr; 1821(4):561-72. PubMed ID: 22353356
[TBL] [Abstract][Full Text] [Related]
6. Activation of RXR/PPARγ underlies neuroprotection by bexarotene in ischemic stroke.
Certo M; Endo Y; Ohta K; Sakurada S; Bagetta G; Amantea D
Pharmacol Res; 2015 Dec; 102():298-307. PubMed ID: 26546745
[TBL] [Abstract][Full Text] [Related]
7. The influence of bexarotene, a selective agonist of the retinoid receptor X (RXR), and tazarotene, a selective agonist of the retinoid acid receptor (RAR), on bone metabolism in rats.
Nowak B; Matuszewska A; Filipiak J; Nikodem A; Merwid-Ląd A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A
Adv Med Sci; 2016 Mar; 61(1):85-9. PubMed ID: 26569440
[TBL] [Abstract][Full Text] [Related]
8. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma.
He BC; Chen L; Zuo GW; Zhang W; Bi Y; Huang J; Wang Y; Jiang W; Luo Q; Shi Q; Zhang BQ; Liu B; Lei X; Luo J; Luo X; Wagner ER; Kim SH; He CJ; Hu Y; Shen J; Zhou Q; Rastegar F; Deng ZL; Luu HH; He TC; Haydon RC
Clin Cancer Res; 2010 Apr; 16(8):2235-45. PubMed ID: 20371684
[TBL] [Abstract][Full Text] [Related]
9. Keratins 2 and 4/13 in reconstituted human skin are reciprocally regulated by retinoids binding to nuclear receptor RARalpha.
Virtanen M; Sirsjö A; Vahlquist A; Törmä H
Exp Dermatol; 2010 Jul; 19(7):674-81. PubMed ID: 20456496
[TBL] [Abstract][Full Text] [Related]
10. Protection from diabetic cardiomyopathy - putative role of the retinoid receptor-mediated signaling.
Rassaf T; Kelm M
J Mol Cell Cardiol; 2013 Jun; 59():179-80. PubMed ID: 23542309
[No Abstract] [Full Text] [Related]
11. Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat.
Schaier M; Liebler S; Schade K; Shimizu F; Kawachi H; Grone HJ; Chandraratna R; Ritz E; Wagner J
J Mol Med (Berl); 2004 Feb; 82(2):116-25. PubMed ID: 14712350
[TBL] [Abstract][Full Text] [Related]
12. Identification of a retinoic acid receptor alpha subtype specific agonist.
Teng M; Duong TT; Klein ES; Pino ME; Chandraratna RA
J Med Chem; 1996 Aug; 39(16):3035-8. PubMed ID: 8759622
[No Abstract] [Full Text] [Related]
13. Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer.
Cesario RM; Stone J; Yen WC; Bissonnette RP; Lamph WW
Cancer Lett; 2006 Aug; 240(2):225-33. PubMed ID: 16271436
[TBL] [Abstract][Full Text] [Related]
14. 9-cis-retinoic acid induces neuronal differentiation of retinoic acid-nonresponsive embryonal carcinoma cells.
Yokota Y; Ohkubo H
Exp Cell Res; 1996 Oct; 228(1):1-7. PubMed ID: 8892963
[TBL] [Abstract][Full Text] [Related]
15. Bexarotene: a promising anticancer agent.
Qu L; Tang X
Cancer Chemother Pharmacol; 2010 Jan; 65(2):201-5. PubMed ID: 19777233
[TBL] [Abstract][Full Text] [Related]
16. Comparison of phenotypic and global gene expression changes in Xenopus tropicalis embryos induced by agonists of RAR and RXR.
Zhu J; Hu L; Li L; Huang X; Shi H
Toxicol Appl Pharmacol; 2017 Sep; 330():40-47. PubMed ID: 28689802
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands.
Elmazar MM; Nau H
Arch Toxicol; 2004 Nov; 78(11):660-8. PubMed ID: 15558240
[TBL] [Abstract][Full Text] [Related]
18. Reduced retinoid signaling in the skin after systemic retinoid-X receptor ligand treatment in mice with potential relevance for skin disorders.
Mihály J; Gericke J; Aydemir G; Weiss K; Carlsen H; Blomhoff R; Garcia J; Rühl R
Dermatology; 2012; 225(4):304-11. PubMed ID: 23296452
[TBL] [Abstract][Full Text] [Related]
19. Preventive and Therapeutic Effects of the Retinoid X Receptor Agonist Bexarotene on Tumors.
Qi L; Guo Y; Zhang P; Cao X; Luan Y
Curr Drug Metab; 2016; 17(2):118-28. PubMed ID: 26806040
[TBL] [Abstract][Full Text] [Related]
20. Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene.
Inoue M; Tanabe H; Nakashima K; Ishida Y; Kotani H
J Nat Prod; 2014 Jul; 77(7):1670-7. PubMed ID: 24959987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
